Is this you? Create Your Porfile
Avatar

Heldin Carl-Henrik

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Heldin Carl-Henrik is active.

Explore More

Publication

Featured researches published by Heldin Carl-Henrik.

Archive | 2014

ΣΥΝΔΥΑΣΜΟΣ ΠΟΥ ΑΠΟΤΕΛΕΙΤΑΙ ΑΠΟ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΜΕΤΑΛΛΑΓΗΣ ΣΗΜΑΤΟΣ ΚΑΙ ΕΝΑ ΠΑΡΑΓΩΓΟ ΕΠΟΘΙΛΟΝΗΣ

Buchdunger Elisabeth; Heldin Carl-Henrik; Ostman Arne; Pietras Kristian; O Reilly Terence; Rothermel John David; Traxler Peter; Wartmann Markus; Brandt Ralf

Archive | 2010

Combination of PDGF receptor tyrosine kinase inhibitor and epothilone derivative, pharmaceutical composition comprising the combination and use thereof

Buchdunger Elisabeth; Heldin Carl-Henrik; Ostman Arne; Pietras Kristian; O'reilly Terence; Rothermel John David; Traxler Peter; Wartmann Markus; Brandt Ralf

Archive | 2010

Blodpladeafledt vækstfaktor D, DNA kodende derfor og anvendelser deraf

Eriksson Ulf; Aase Karin; Ponten Annica; Uutela Marko; Alitalo Kari; Oestman Arne; Heldin Carl-Henrik; Li Xuri

Archive | 2009

Kombination indeholdende en signaltransduktionsinhibitor og et epothilonderivat

Buchdunger Elisabeth; Heldin Carl-Henrik; Oestman Arne; Pietras Kristian; O'reilly Terence; Rothermel John David; Traxler Peter; Wartmann Markus; Brandt Ralf

Archive | 2009

COMBINACION QUE COMPRENDE UN INHIBIDOR DE TRANSDUCCION DE SEÑAL Y UN DERIVADO EPOTILONA.

Buchdunger Elisabeth; Heldin Carl-Henrik; Ostman Arne; Pietras Kristian; O'reilly Terence; Rothermel John David

Archive | 2009

KOMBINATION ENTHALTEND EINEN INHIBITOR DER SIGNALTRANSDUKTION UND EIN EPOTHILONDERIVAT

Buchdunger Elisabeth; Heldin Carl-Henrik; Oestman Arne; Pietras Kristian; O'reilly Terence; Rothermel John David; Traxler Peter; Wartmann Markus; Brandt Ralf

Archive | 2008

Kombinasjon som omfatter en signaltransduksjoninhibitor og et epotilonderivat, farmasoytisk sammensetning som inneholder nevnte kombinasjon, samt anvendelse derav ved behandling av en proliferativ sykdom.

Heldin Carl-Henrik; Traxler Peter; O'reilly Terence; Brandt Ralf; Ostman Arne; Pietras Kristian; Rothermel John David; Wartmann Markus

Archive | 2006

Combination comprising an active ingredient which decreases the activity of the epidermal growth factor (EGF) and an epothilone derivative

Brandt Ralf; Buchdunger Elisabeth; Heldin Carl-Henrik; Ostman Arne; Pietras Kristian; Terence O'reilly; John David Rothermel; Peter Traxler; Markus Wartmann

Archive | 2003

Platelet-derived growth factor D (PDGF-D), DNA coding therefor, and uses thereof for invasions of tumor cells

Eriksson Ulf; Aase Karin; Ponten Annica; Li Xuri; Uutela Marko; Alitalo Kari; Oestman Arne; Heldin Carl-Henrik

Archive | 2003

Kombinasjon som omfatter en signaltransduksjoninhibitor og et epotilonderivat

Brandt Ralf; Heldin Carl-Henrik; Oestman Arne; Pietras Kristian; O'reilly Terence; Rothermel John David; Traxler Peter; Wartmann Markus

Explore More

Collaboration

Dive into the Heldin Carl-Henrik's collaboration.

Top Co-Authors
Avatar

Pietras Kristian

Novartis

View shared research outputs
Top Co-Authors
Avatar

Brandt Ralf

Novartis

View shared research outputs
Top Co-Authors
Avatar

Rothermel John David

Novartis

View shared research outputs
Top Co-Authors
Avatar

Buchdunger Elisabeth

Novartis

View shared research outputs
Top Co-Authors
Avatar

O'reilly Terence

Novartis

View shared research outputs
Top Co-Authors
Avatar

Oestman Arne

Novartis

View shared research outputs
Top Co-Authors
Avatar

Traxler Peter

Novartis

View shared research outputs
Top Co-Authors
Avatar

Wartmann Markus

Novartis

View shared research outputs
Top Co-Authors
Avatar

Markus Wartmann

Novartis

View shared research outputs
Top Co-Authors
Avatar

Peter Traxler

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge